SCHOTT introduces an online shop with low minimum order quantities to overcome the challenges associated with conventional purchase order procedures.

GlaxoSmithKline has launched a vaccine awareness campaign in the USA as immunization rates drop amidst the pandemic.

Nominations are now open for The Medicine Maker 2021 Power List.

Amgen has brought the Multi-Attribute Method (MAM) into the mainstream, but what’s next for this analytical workflow. Click to read article

Can genomic medicine usher in a new era of curative treatments for neurological diseases? Experts from Sangamo give their views.

Amgen developed the Multi-Attribute Method (MAM) to obtain high-fidelity understanding of the quality of its own biologics. Click to read article

A breakthrough in transgenic mice opens the door to “Humabodies.”

We ask medicine makers around the world to tell us how their professional and personal lives have changed over the course of the COVID-19 crisis.

How can we achieve gender parity in drug dosing?

We speak with Laertis Ikonomou and Dan Weiss about the ISCT's work to combat unproven cell therapies.